Kintara Therapeutics (KTRA) Is Rising Again: Financial Results for Fiscal Year 2021

Kintara Therapeutics stock rose by 14.52% yesterday and was trading at $0.9560. Today, the price of the company’s stock in the pre-market has increased by 16.10% and amounted to $1.11. Over the past couple of days, the stock price has increased significantly. On October 11, the stock was trading at $0.7864. the next day, the price jumped to $0.9700. Recently, Kintara Therapeutics announced financial results for its fiscal year ended June 30, 2021, and provided corporate information.

Kintara Therapeutics has entered into securities purchase agreements with institutional investors to raise $15 million in gross profit. On September 28, 2021, funding from this registered direct offering, which was priced at a premium to the market, was completed, providing funds for continuing clinical studies and corporate working capital needs. The GBM Flexible Registration Research Unit VAL-083, sponsored by the Global Adaptive Research Coalition, has expanded its patient registration capabilities in the United States by activating additional clinical trial sites for glioblastoma (GBM) patients (GCAR).

Lora Nilsson

Finance and Business reporterAfter graduating high school. Lora decided to travel and blog as a part-timer. Today she enjoys what she loves and works remotely as our finance and business reporter